Skip to main content

Table 1 Characteristics of study population at baseline and directly, 3, 6 & 9 months after spa-treatment including radon

From: Sustained improvements in EQ-5D utility scores and self-rated health status in patients with ankylosing spondylitis after spa treatment including low-dose radon – an analysis of prospective radon indication registry data

 

Baselinea

Time after intervention

directly

3 months

6 months

9 months

Age, mean (SD); range

51.80 (10.14);

19.00–79.00

 

Women, n (%)

128 (44.00)

Body mass index, mean (SD); range

26.37 (4.25);

18.37–39.56

EQ-5D utility index1, mean (SD); range

0.79 (0.17);

0.01–1.00

0.88 (0.11);

0.36–1.00

0.87 (0.12);

0.24–1.00

0.85 (0.13);

0.19–1.00

0.83 (0.16);

0.08–1.00

EQ-VAS2, mean (SD); range

62.51 (18.01);

15.00–100.00

74.88 (17.10);

2.00–100.00

74.76 (15.41)

20.00–100.00

71.46 (15.52)

18.00–98.00

67.23 (18.00)

20.00–100.00

Clinically relevant improvement

EQ-5D utility index3, n (%)

 

164 (56.36)

160 (54.98)

130 (44.67)

107 (36.77)

Clinically relevant improvement

EQ-VAS3, n (%)

207 (70.10)

191 (65.64)

170 (58.42)

139 (47.77)

  1. adirectly before intervention
  2. 1von Neumann-Morgenstern utility value for current health based on 5 dimensions of EuroQol (i.e. mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), range 0–1 (i.e. 0 = death, 1 = perfect health)
  3. 2self-rated health status on a graduated (0–100) scale, 0 = ‘The worst health you can imagine’, 100 = ‘The best health you can imagine’
  4. 3clinically relevant improvement. ≥ 0.05 for EQ-5D utility index and ≥ 5.00 for EQ-VAS)